Model DetailsLeukocyte lymphoma
Model Name |
Leukocyte lymphoma | Strain |
(C57BL/6N x C3H/HeN)F1 |
Tumor Inducing Agent(s) |
Diet : calorie restricted |
Tumor Synonyms |
lymphoma mal • lymphoma |
Strain Synonyms |
BCF1 • B6C3F1 • C57BL/6NxC3H/HeN F1 • B6C3F1 • (C57BL/6N X C3H/HeN)F1 |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Leukocyte | Female |
7.1% (1 of 14 mice) |
24 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
2.4% (1 of 42 mice) |
12-24 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
0% (0 of 15 mice) |
30 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
6.7% (1 of 15 mice) |
36 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
13.3% (2 of 15 mice) |
42 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
9.1% (2 of 22 mice) |
42-48 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
4.3% (4 of 94 mice) |
12-48 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
0% (0 of 7 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
40% (8 of 20 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
50% (17 of 34 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
25% (10 of 40 mice) |
42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
46.7% (7 of 15 mice) |
48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
30.9% (17 of 55 mice) |
42-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
36.2% (42 of 116 mice) |
12-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
50% (1 of 2 mice) |
18 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
100% (1 of 1 mice) |
24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
66.7% (2 of 3 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
33.3% (1 of 3 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
13.3% (2 of 15 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
36.8% (7 of 19 mice) |
42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
26.7% (4 of 15 mice) |
48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
32.4% (11 of 34 mice) |
42-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
29.1% (16 of 55 mice) |
12-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Female |
23.4% (62 of 265 mice) |
12-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
7.1% (1 of 14 mice) |
24 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
2.4% (1 of 42 mice) |
12-24 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
0% (0 of 15 mice) |
30 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
0% (0 of 15 mice) |
36 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
10.5% (2 of 19 mice) |
42 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
7.7% (1 of 13 mice) |
48 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
9.4% (3 of 32 mice) |
42-48 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
3.8% (4 of 104 mice) |
12-48 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
0% (0 of 3 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
33.3% (3 of 9 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
25% (5 of 20 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
18.5% (5 of 27 mice) |
42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
11.6% (5 of 43 mice) |
48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
14.3% (10 of 70 mice) |
42-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
17.6% (18 of 102 mice) |
12-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
0% (0 of 4 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
0% (0 of 3 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
38.5% (5 of 13 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
3.8% (1 of 26 mice) |
48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
2.8% (1 of 36 mice) |
42-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
10.7% (6 of 56 mice) |
12-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte | Male |
10.7% (28 of 262 mice) |
12-48 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |